Uwe Tröger

590 total citations
29 papers, 426 citations indexed

About

Uwe Tröger is a scholar working on Pharmacology, Molecular Medicine and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Uwe Tröger has authored 29 papers receiving a total of 426 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmacology, 4 papers in Molecular Medicine and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Uwe Tröger's work include Antibiotics Pharmacokinetics and Efficacy (6 papers), Antibiotic Resistance in Bacteria (4 papers) and Drug-Induced Adverse Reactions (2 papers). Uwe Tröger is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (6 papers), Antibiotic Resistance in Bacteria (4 papers) and Drug-Induced Adverse Reactions (2 papers). Uwe Tröger collaborates with scholars based in Germany, Austria and Hungary. Uwe Tröger's co-authors include Stefanie M. Bode‐Böger, Jens Martens‐Lobenhoffer, Frank Meyer, Ivan Tanev, Ruediger C. Braun‐Dullaeus, Friedrich‐Wilhelm Röhl, Brian C. Werner, P. S. Schönhöfer, Peter Malfertheiner and P. Mailänder and has published in prestigious journals such as Anesthesia & Analgesia, Clinical Pharmacology & Therapeutics and Biochimica et Biophysica Acta (BBA) - Bioenergetics.

In The Last Decade

Uwe Tröger

29 papers receiving 412 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Uwe Tröger Germany 12 144 68 55 53 52 29 426
A Mignot France 10 134 0.9× 57 0.8× 30 0.5× 37 0.7× 48 0.9× 27 328
Régis Bouquié France 14 171 1.2× 67 1.0× 25 0.5× 40 0.8× 110 2.1× 33 498
F. Demotes‐Mainard France 13 180 1.3× 39 0.6× 40 0.7× 25 0.5× 36 0.7× 41 383
Jill Fiedler‐Kelly United States 13 161 1.1× 81 1.2× 59 1.1× 56 1.1× 110 2.1× 47 653
Staffan Rosenborg Sweden 13 71 0.5× 43 0.6× 59 1.1× 33 0.6× 75 1.4× 24 449
Anna Wiela−Hojeńska Poland 12 113 0.8× 66 1.0× 40 0.7× 21 0.4× 72 1.4× 42 416
Robert C. Sonders United States 12 156 1.1× 96 1.4× 33 0.6× 38 0.7× 75 1.4× 18 441
Ann Allen United Kingdom 17 233 1.6× 109 1.6× 27 0.5× 89 1.7× 79 1.5× 45 873
H M Siefert Germany 13 167 1.2× 73 1.1× 34 0.6× 55 1.0× 73 1.4× 22 411
Richard Scheife United States 12 108 0.8× 72 1.1× 39 0.7× 16 0.3× 90 1.7× 21 602

Countries citing papers authored by Uwe Tröger

Since Specialization
Citations

This map shows the geographic impact of Uwe Tröger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Uwe Tröger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Uwe Tröger more than expected).

Fields of papers citing papers by Uwe Tröger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Uwe Tröger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Uwe Tröger. The network helps show where Uwe Tröger may publish in the future.

Co-authorship network of co-authors of Uwe Tröger

This figure shows the co-authorship network connecting the top 25 collaborators of Uwe Tröger. A scholar is included among the top collaborators of Uwe Tröger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Uwe Tröger. Uwe Tröger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Martens‐Lobenhoffer, Jens, et al.. (2019). Stability of meropenem in plasma versus dried blood spots (DBS). Journal of Pharmaceutical and Biomedical Analysis. 170. 279–284. 18 indexed citations
2.
Bode‐Böger, Stefanie M., et al.. (2014). Successful treatment of extensively drug-resistant Pseudomonas aeruginosa osteomyelitis using a colistin- and tobramycin-impregnated PMMA spacer. International Journal of Antimicrobial Agents. 44(4). 363–366. 16 indexed citations
3.
Bode‐Böger, Stefanie M., et al.. (2013). Intravenous colistin in a patient with serious burns and borderline syndrome: The benefits of therapeutic drug monitoring. International Journal of Antimicrobial Agents. 42(4). 357–360. 29 indexed citations
4.
Tröger, Uwe, et al.. (2012). Decreased meropenem levels in Intensive Care Unit patients with augmented renal clearance: benefit of therapeutic drug monitoring. International Journal of Antimicrobial Agents. 40(4). 370–372. 55 indexed citations
5.
Westphal, Sabine, et al.. (2010). Pharmacokinetics and dose recommendations of Niaspan(R) in chronic kidney disease and dialysis patients. Nephrology Dialysis Transplantation. 26(1). 276–282. 10 indexed citations
6.
Tröger, Uwe, Jens Martens‐Lobenhoffer, Arne Kandulski, et al.. (2010). Omeprazole-induced cough in a patient with gastroesophageal reflux disease. European Journal of Gastroenterology & Hepatology. 22(7). 880–882. 9 indexed citations
7.
Martens‐Lobenhoffer, Jens, Endre Sulyok, Endre Czeiter, et al.. (2007). Determination of cerebrospinal fluid concentrations of arginine and dimethylarginines in patients with subarachnoid haemorrhage. Journal of Neuroscience Methods. 164(1). 155–160. 25 indexed citations
8.
Martens‐Lobenhoffer, Jens, et al.. (2007). Determination of ornithine in human plasma by hydrophilic interaction chromatography–tandem mass spectrometry. Journal of Chromatography B. 855(2). 271–275. 33 indexed citations
9.
Martens‐Lobenhoffer, Jens, et al.. (2007). Enantioselective quantification of omeprazole and its main metabolites in human serum by chiral HPLC–atmospheric pressure photoionization tandem mass spectrometry. Journal of Chromatography B. 857(2). 301–307. 29 indexed citations
10.
Tröger, Uwe, Hartmut Lins, J.M. Scherrmann, Claus-Werner Wallesch, & Stefanie M. Bode‐Böger. (2005). Tetraparesis associated with colchicine is probably due to inhibition by verapamil of the P-glycoprotein efflux pump in the blood-brain barrier. BMJ. 331(7517). 613.1–613.1. 16 indexed citations
11.
Tröger, Uwe, et al.. (2002). Severe myalgia from an interaction between treatments with pantoprazole and methotrexate. BMJ. 324(7352). 1497–1497. 38 indexed citations
12.
Tröger, Uwe, et al.. (2002). Drug points. 5(4). 189–190. 1 indexed citations
13.
Martens‐Lobenhoffer, Jens, et al.. (2001). The Effect of Anxiety and Personality on the Pharmacokinetics of Oral Midazolam. Anesthesia & Analgesia. 92(3). 621–624. 6 indexed citations
14.
Martens‐Lobenhoffer, Jens, et al.. (2001). The Effect of Anxiety and Personality on the Pharmacokinetics of Oral Midazolam. Anesthesia & Analgesia. 92(3). 621–624. 10 indexed citations
15.
Tröger, Uwe, et al.. (1998). Validity of advertising claims for multivitamin preparation Vitacor 20/90 on the internet. BMJ. 317(7165). 1069–1071. 4 indexed citations
16.
Schönhöfer, P. S., Brian C. Werner, & Uwe Tröger. (1997). Drug points: Ocular damage associated with proton pump inhibitors: Table 1. BMJ. 314(7097). 1805–1805. 22 indexed citations
17.
Tröger, Uwe, et al.. (1996). Sulthiame-associated mild compensated metabolic acidosis.. PubMed. 34(12). 542–5. 5 indexed citations
18.
Meyer, Frank, Uwe Tröger, & Friedrich‐Wilhelm Röhl. (1996). Adverse nondrug reactions: An update*. Clinical Pharmacology & Therapeutics. 60(3). 347–352. 23 indexed citations
19.
Tröger, Uwe & Frank Meyer. (1995). Influence of Endogenous and Exogenous Effectors on the Pharmacokinetics of Theophylline. Clinical Pharmacokinetics. 28(4). 287–314. 30 indexed citations
20.
Halangk, Walter, Uwe Tröger, & Ralf Bohnensack. (1990). Quantification of aerobic energy turnover in epididymal bull spermatozoa. Biochimica et Biophysica Acta (BBA) - Bioenergetics. 1015(2). 243–247. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A Mignot Breakdown of academic impact, for papers by Régis Bouquié Breakdown of academic impact, for papers by F. Demotes‐Mainard Breakdown of academic impact, for papers by Jill Fiedler‐Kelly Breakdown of academic impact, for papers by Staffan Rosenborg Breakdown of academic impact, for papers by Anna Wiela−Hojeńska Breakdown of academic impact, for papers by Robert C. Sonders Breakdown of academic impact, for papers by Ann Allen Breakdown of academic impact, for papers by H M Siefert Breakdown of academic impact, for papers by Richard Scheife
Rankless by CCL
2026